T. Rowe Price Associates’s CRH CRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239M Buy
2,235,569
+106,920
+5% +$11.8M 0.02% 466
2026
Q1
$224M Sell
2,128,649
-11,922
-0.6% -$1.4M 0.03% 433
2025
Q4
$267M Buy
2,140,571
+1,586,810
+287% +$189M 0.03% 382
2025
Q3
$66.4M Buy
553,761
+37,537
+7% +$3.96M 0.01% 712
2025
Q2
$47.4M Buy
516,224
+13,491
+3% +$1.23M 0.01% 742
2025
Q1
$44.2M Buy
502,733
+35,160
+8% +$3.46M 0.01% 758
2024
Q4
$43.3M Sell
467,573
-54,346
-10% -$5.23M 0.01% 800
2024
Q3
$48.4M Buy
521,919
+5,446
+1% +$457K 0.01% 766
2024
Q2
$38.7M Buy
+516,473
New +$41.2M ﹤0.01% 797
2024
Q1
– Sell
-3,458
Closed -$240K – 2962
2023
Q4
$240K Buy
+3,458
New +$209K ﹤0.01% 2471

Other funds holding CRH

T. Rowe Price Associates's CRH Position: Q2 2026 in Review

T. Rowe Price Associates increased its CRH (CRH) stake by 5% in Q2 2026, buying an estimated $11.8M and bringing the position to 2,235,569 shares worth $239M. The position accounts for 0.02% of the portfolio, ranked #466.

T. Rowe Price Associates first reported a position in CRH in Q4 2023 and has held it in 10 quarters since. The position peaked at $267M in Q4 2025. 1,035 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • T. Rowe Price Associates held 2,235,569 shares of CRH worth $239M as of Q2 2026.
  • T. Rowe Price Associates bought 106,920 CRH shares in Q2 2026, an estimated $11.8M.
  • CRH made up 0.02% of T. Rowe Price Associates's portfolio in Q2 2026, its #466 holding.
  • T. Rowe Price Associates first reported a position in CRH in Q4 2023 and has held it in 10 quarters since.
  • T. Rowe Price Associates's CRH position peaked at $267M in Q4 2025.
  • 1,035 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.